Ductal carcinoma in situ of the breast: Correlation between histologic classifications and biologic markers

被引:0
|
作者
Moreno, A
Lloveras, B
Figueras, A
Escobedo, A
Ramon, JM
Sierra, A
Fabra, A
机构
[1] CIUTAT SANITARIA BELLVITGE,DEPT EPIDEMIOL,BARCELONA,SPAIN
[2] INST CATALA ONCOL,DEPT ONCOL,BARCELONA,SPAIN
[3] INST RECERCA ONCOL,DEPT CANC & METASTASIS,BARCELONA,SPAIN
关键词
breast; ductal carcinoma in situ; immunohistochemistry;
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The expression of hormone receptors (estrogen and progesterone), c-erb-B2 (neu), p53, and Ki-67) tvas studied by immunohistochemical analysis in a series of 94 carcinomas in situ of the breast. The tumors were classified in two (high grade vs. low grade) and three (high grade vs. intermediate grade vs. low grade) categories. High-grade carcinomas were well defined by biologic markers showing statistically significant differences for all of the parameters tested. No clear biologic distinction, however, between low-grade and intermediate-grade cancers could be obtained. Negative progesterone receptors and a high proliferative index are the best discriminant parameters for the final assignment of doubtful cases.
引用
收藏
页码:1088 / 1092
页数:5
相关论文
共 50 条
  • [21] Genetic alterations in ductal carcinoma in situ of the breast: Association with histologic type
    van de Vijver, MJ
    Peterse, JL
    Vos, C
    ter Haar, N
    MODERN PATHOLOGY, 1998, 11 (01) : 29A - 29A
  • [22] Genetic alterations in ductal carcinoma in situ of the breast: Association with histologic type
    vandeVijver, MJ
    Peterse, JL
    Vos, C
    terHaar, N
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 288 - 288
  • [23] DUCTAL CARCINOMA IN-SITU OF THE BREAST, REPRODUCIBILITY OF HISTOLOGIC SUBTYPE ANALYSIS
    SCOTT, M
    AXELSSON, K
    LAGIOS, M
    ANDERSON, T
    ROGERS, L
    PAGE, D
    LABORATORY INVESTIGATION, 1995, 72 (01) : A25 - A25
  • [24] Ductal carcinoma in situ of the breast: Frequency of biomarkers according to histologic subtype
    Bhoola, S
    DeRose, PB
    Cohen, C
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 1999, 7 (02): : 108 - 115
  • [25] Predicting the biologic behavior of ductal carcinoma in situ: An analysis of molecular markers - Discussion
    Scott-Conner, C
    Bell, RH
    Estes, NC
    Pollak, R
    Hieken
    SURGERY, 2001, 130 (04) : 600 - 601
  • [26] Grading of ductal breast carcinoma by cytomorphology and image morphometry with histologic correlation
    Tahlan, A
    Nijhawan, R
    Joshi, K
    ANALYTICAL AND QUANTITATIVE CYTOLOGY AND HISTOLOGY, 2000, 22 (03): : 193 - 198
  • [27] Correlation Between Sonographic Findings and Clinicopathologic and Biologic Features of Pure Ductal Carcinoma In Situ in 691 Patients
    Scoggins, Marion E.
    Fox, Patricia S.
    Kuerer, Henry M.
    Rauch, Gaiane M.
    Benveniste, Ana P.
    Park, Young Mi
    Lari, Sara A.
    Krishnamurthy, Savitri
    Yang, Wei T.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2015, 204 (04) : 878 - 888
  • [28] Impact of Prognostic Markers on the Therapy of Ductal Breast Carcinoma in situ
    Boehm, J.
    Zikan, M.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2011, 71 (11) : 967 - 972
  • [29] Molecular markers in ductal carcinoma in situ (DICIS) of the breast.
    Polyak, K
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2002, 11 (10) : 1261S - 1262S
  • [30] Immunohistochemical analysis on biological markers in ductal carcinoma in situ of the breast
    Iwase H.
    Ando Y.
    Ichihara S.
    Toyoshima S.
    Nakamura T.-A.
    Karamatsu S.
    Ito Y.
    Yamashita H.
    Toyama T.
    Omoto Y.
    Fujii Y.
    Mitsuyama S.
    Kobayashi S.
    Breast Cancer, 2001, 8 (2) : 98 - 104